vendredi 17 mai 2013

Press Review (May 18, 2013) – Revue de presse (18 mai 2013)







Washington: Cancer Patients More Prone to Bankruptcy
A study of cancer patients in Washington State has found they were twice as likely to file for bankruptcy as people without cancer. The study, led by researchers from the Fred Hutchinson Cancer Research Center in Seattle, linked bankruptcy court records and information from the regional cancer registry on about 200,000 cancer patients, and compared them with a similar group of people from the same area who did not have cancer. Young people with cancer experienced the highest bankruptcy rates, the study found, up to 10 times the rate of bankruptcy filings among older age groups.
By Sabrina Tavernise. In The New York Times

Seeking Calm on the Cancer Ward
When people choose to have their leukemia treated aggressively, it’s a big commitment, more so than for almost any other cancer.
With this therapy — three days of the drug daunorubicin, which comes in a reddish color so distinctive that one of my patients, a former chemist, used it in his professional life as a dye for plastics, and seven days of the drug cytarabine, which is infused continuously over 168 hours — we offer them the chance to be cured of a disease moving like wildfire with a stiff breeze behind it at the height of drought.
By Mikkael L. Sekkeres. In The New York Times (blog)      

Melanoma Treatment Harnesses Immune System to Combat Cancer Cells
A study of cancer patients in Washington State has found they were twice as likely to file for bankruptcy as people without cancer. The study, led by researchers from the Fred Hutchinson Cancer Research Center in Seattle, linked bankruptcy court records and information from the regional cancer registry on about 200,000 cancer patients, and compared them with a similar group of people from the same area who did not have cancer. Young people with cancer experienced the highest bankruptcy rates, the study found, up to 10 times the rate of bankruptcy filings among older age groups.
By Andrew Pollock. In The New York Times

Cancer patients condemn hospital care
Some go hungry, receive the wrong drugs or feel so uncared for they consider abandoning treatment.
By Denis Campbell. In The Guardian               

Cancer genetics in music and film
“Decoding Annie Parker,” which premiered in New York last month, is coming to Seattle June 6 and 8 through SIFF. “In this amazing true story, the lives of cancer-stricken Annie Parker and UW geneticist Mary-Claire King intertwine, leading to the world-changing discovery of the BRCA1 breast cancer gene.” Helen Hunt plays King, and Samantha Morton plays Parker, who now speaks around the world about her experiences.
By Carol M. Ostrom. In The Seattle Times       



Cancer du sein : le coup de pouce de Jolie au vendeur de tests génétiques
En annonçant sa mastectomie préventive, Angelina Jolie a, malgré elle, fait un cadeau à une société controversée outre-Atlantique : l’action de Myriad Genetics, le fabricant du test de dépistage, a grimpé de 4% sur une seule journée. Mais Myriad est poursuivie par des défenseurs des libertés civiles et des scientifiques pour avoir voulu breveter le vivant.
Par Sophie Caillat. Dans Rue89

Cancer du poumon : une prise de sang pour repérer les anomalies génétiques
Une équipe de chercheurs français a mis au point une technique qui permettrait, à l’aide d’une simple prise de sang, d'identifier les patients susceptibles de bénéficier d'un traitement ciblé contre le cancer du poumon
Par Emmanuel Perrin. Dans MaxiSciences


Aucun commentaire:

Enregistrer un commentaire